Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Clinical and Economic Outcomes in Elderly Advanced Renal Cell Carcinoma Patients Starting Pazopanib or Sunitinib Treatment: A Retrospective Medicare Claims Analysis.
Vogelzang NJ, Pal SK, Ghate SR, Swallow E, Li N, Peeples M, Zichlin ML, Meiselbach MK, Perez JR, Agarwal N. Vogelzang NJ, et al. Among authors: zichlin ml. Adv Ther. 2017 Nov;34(11):2452-2465. doi: 10.1007/s12325-017-0628-2. Epub 2017 Oct 26. Adv Ther. 2017. PMID: 29076108 Free PMC article.
Real-World Economic Outcomes During Time on Treatment Among Patients Who Initiated Sunitinib or Pazopanib as First Targeted Therapy for Advanced Renal Cell Carcinoma: A Retrospective Analysis of Medicare Claims Data.
Vogelzang NJ, Pal SK, Ghate SR, Li N, Swallow E, Peeples M, Zichlin ML, Meiselbach MK, Perez JR, Agarwal N. Vogelzang NJ, et al. Among authors: zichlin ml. J Manag Care Spec Pharm. 2018 Jun;24(6):525-533. doi: 10.18553/jmcp.2018.24.6.525. J Manag Care Spec Pharm. 2018. PMID: 29799328 Free PMC article.
[No title available]
[No authors listed] [No authors listed] PMID: 36163837
Treatment patterns and overall survival of patients with double-class and triple-class refractory multiple myeloma: a US electronic health record database study.
Wang PF, Yee CW, Gorsh B, Zichlin ML, Paka P, Bhak RH, Boytsov N, Khanal A, Noman A, DerSarkissian M, Ferrante S, Duh MS. Wang PF, et al. Among authors: zichlin ml. Leuk Lymphoma. 2023 Feb;64(2):398-406. doi: 10.1080/10428194.2022.2140284. Epub 2022 Nov 21. Leuk Lymphoma. 2023. PMID: 36408998 Free article.
32 results